Cargando…

Interpreting Bisphenol A Absorption in the Canine Oral Cavity: Gayrard et al. Respond

Detalles Bibliográficos
Autores principales:	Gayrard, Véronique, Lacroix, Marlène Z., Collet, Séverine H., Viguié, Catherine, Bousquet-Melou, Alain, Toutain, Pierre-Louis, Picard-Hagen, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Institute of Environmental Health Sciences 2013
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855523/ https://www.ncbi.nlm.nih.gov/pubmed/24284012 http://dx.doi.org/10.1289/ehp.1307424R

Ejemplares similares

High Bioavailability of Bisphenol A from Sublingual Exposure
por: Gayrard, Véronique, et al.
Publicado: (2013)

Comment on “In Vitro Effects of Bisphenol A β-D-Glucuronide (BPA-G) on Adipogenesis in Human and Murine Preadipocytes”
por: Gayrard, Véronique, et al.
Publicado: (2015)

Prediction of human prenatal exposure to bisphenol A and bisphenol A glucuronide from an ovine semi-physiological toxicokinetic model
por: Gauderat, Glenn, et al.
Publicado: (2017)

Oral Systemic Bioavailability of Bisphenol A and Bisphenol S in Pigs
por: Gayrard, Véronique, et al.
Publicado: (2019)

Exposure Conditions and Pharmacokinetic Principles: Interpreting Bisphenol A Absorption in the Canine Oral Cavity
por: Teeguarden, Justin G., et al.
Publicado: (2013)

Contribution of Reliable Chromatographic Data in QSAR for Modelling Bisphenol Transport across the Human Placenta Barrier
por: Gély, Clémence A., et al.
Publicado: (2023)

In vitro Degradation of Antimicrobials during Use of Broth Microdilution Method Can Increase the Measured Minimal Inhibitory and Minimal Bactericidal Concentrations
por: Lallemand, Elodie A., et al.
Publicado: (2016)

Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice
por: Vasseur, Maleck V., et al.
Publicado: (2017)

A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients
por: Bousquet-Mélou, Alain, et al.
Publicado: (2021)

Are BPA Substitutes as Obesogenic as BPA?
por: Oliviero, Fabiana, et al.
Publicado: (2022)

Population Pharmacokinetic Study of Cefazolin Used Prophylactically in Canine Surgery for Susceptibility Testing Breakpoint Determination
por: Cagnardi, Petra, et al.
Publicado: (2018)

Differential Activity of the Combination of Vancomycin and Amikacin on Planktonic vs. Biofilm-Growing Staphylococcus aureus Bacteria in a Hollow Fiber Infection Model
por: Broussou, Diane C., et al.
Publicado: (2018)

Comparison of Serum Bisphenol A Concentrations in Mice Exposed to Bisphenol A through the Diet versus Oral Bolus Exposure
por: Sieli, Paizlee T., et al.
Publicado: (2011)

Bisphenol A in Thermal Paper Receipts: Taylor et al. Respond
por: Taylor, Julia A., et al.
Publicado: (2012)

Dynamic interactions between cephalexin and macrophages on different Staphylococcus aureus inoculum sizes: a tripartite in vitro model
por: Lallemand, Elodie Anne, et al.
Publicado: (2021)

Comparison of Bisphenol A and Bisphenol S Percutaneous Absorption and Biotransformation
por: Liu, Jiaying, et al.
Publicado: (2019)

Comparison of the In vitro Activity of Five Antimicrobial Drugs against Staphylococcus pseudintermedius and Staphylococcus aureus Biofilms
por: Ferran, Aude A., et al.
Publicado: (2016)

Use of Mixture Dosing and Nonlinear Mixed Effect Modeling of Eight Environmental Contaminants in Rabbits to Improve Extrapolation Value of Toxicokinetic Data
por: Gayrard, Véronique, et al.
Publicado: (2021)

Levers to Improve Antibiotic Treatment of Lambs via Drinking Water in Sheep Fattening Houses: The Example of the Sulfadimethoxine/Trimethoprim Combination
por: Ferran, Aude A., et al.
Publicado: (2020)

Veterinary Medicine Needs New Green Antimicrobial Drugs
por: Toutain, Pierre-Louis, et al.
Publicado: (2016)

Implementing Precision Antimicrobial Therapy for the Treatment of Bovine Respiratory Disease: Current Limitations and Perspectives
por: Lhermie, Guillaume, et al.
Publicado: (2017)

Bacterial Species-Specific Activity of a Fluoroquinolone against Two Closely Related Pasteurellaceae with Similar MICs: Differential In Vitro Inoculum Effects and In Vivo Efficacies
por: Lhermie, Guillaume, et al.
Publicado: (2015)

Bisphenol A: vom Saal and Hughes Respond
por: vom Saal, Frederick S., et al.
Publicado: (2006)

The Selection of Antibiotic- and Bacteriophage-Resistant Pseudomonas aeruginosa Is Prevented by Their Combination
por: Ferran, Aude A., et al.
Publicado: (2022)

Acknowledging Receipts? New Evidence for Dermal Absorption of Bisphenols
por: Schmidt, Silke
Publicado: (2020)

Evidence for Bisphenol B Endocrine Properties: Scientific and Regulatory Perspectives
por: Serra, Hélène, et al.
Publicado: (2019)

Comparison of in vitro static and dynamic assays to evaluate the efficacy of an antimicrobial drug combination against Staphylococcus aureus
por: Broussou, Diane C., et al.
Publicado: (2019)

Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?
por: Concordet, Didier, et al.
Publicado: (2019)

Biased computation of probability of target attainment for antimicrobial drugs
por: Toutain, Pierre‐Louis, et al.
Publicado: (2023)

Authors’ Reply to Castello-Bridoux et al.: “Comment on Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Nicolas: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Coste et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Lechat et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Nicolas: “Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Yu et al.: “Levothyrox(®) New and Old Formulations: Are They Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Krebs-Brown et al. Comment on: “Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”
por: Concordet, D., et al.
Publicado: (2019)

ABSORPTION FROM THE PERICARDIAL CAVITY
por: Drinker, Cecil K., et al.
Publicado: (1931)

En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach
por: Toutain, Pierre-Louis, et al.
Publicado: (2017)

Bisphenol S Impaired Human Granulosa Cell Steroidogenesis in Vitro
por: Amar, Sarah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hc3rbs6jmjvj3bl4ie6slttot3